CANNABIS SUISSE Swings to Profit Amidst Zero Revenue, Going Concern Doubts

Ticker: CSUI · Form: 10-Q · Filed: Oct 10, 2025 · CIK: 1680132

Sentiment: bearish

Topics: Cannabis, Real Estate, Going Concern, Micro-cap, Related Party Transactions, Revenue Decline, Net Income Swing

TL;DR

**CSUI's 'profit' is a mirage; zero revenue and a going concern warning mean this stock is a hard pass for any serious trader.**

AI Summary

CANNABIS SUISSE CORP. (CSUI) reported a net income of $13,907 for the three months ended August 31, 2025, a significant improvement from a net loss of $535,086 in the same period last year. This turnaround was primarily driven by a substantial amortization of debt premium totaling $114,739, coupled with the absence of a $551,677 loss on settlement of debt that occurred in the prior year. However, the company's rental income plummeted from $7,500 in Q3 2024 to $0 in Q3 2025, indicating a complete cessation of its primary revenue stream. Operating expenses increased to $84,535 from $74,983 year-over-year, mainly due to higher general and administrative expenses of $62,474. The company continues to face substantial doubt about its ability to continue as a going concern, with an accumulated deficit of $3,043,139 as of August 31, 2025, and limited revenues. Cash in escrow decreased from $2,850 to $305, and total assets declined from $635,075 to $570,344 over the quarter. The company relies on related party funding, with advances from related parties increasing by $9,000 to $28,400 during the period.

Why It Matters

This filing reveals a critical juncture for CANNABIS SUISSE. While a swing to net income of $13,907 might appear positive, the complete absence of rental revenue, previously its sole income source, is a major red flag for investors. The company's reliance on related party funding and a persistent 'going concern' warning underscore its precarious financial health, suggesting high risk for new investments. Competitors in the cannabis real estate sector, if any, would see CSUI's struggles as a potential market vacuum, while employees face job insecurity given the lack of operational revenue. The broader market should view this as a cautionary tale regarding micro-cap companies with unstable business models.

Risk Assessment

Risk Level: high — The company explicitly states 'substantial doubt about the Company's ability to continue as a going concern' due to 'limited revenues and accumulated deficit of $3,043,139 as of August 31, 2025.' Furthermore, rental income, its only reported revenue, dropped from $7,500 to $0 for the three months ended August 31, 2025, indicating a complete lack of operational income.

Analyst Insight

Investors should exercise extreme caution and likely avoid CANNABIS SUISSE CORP. given the explicit going concern warning and the complete cessation of its only reported revenue stream. The reported net income is not from sustainable operations but from accounting adjustments related to debt, making it a poor indicator of future performance.

Financial Highlights

debt To Equity
N/A
revenue
$0
operating Margin
N/A
total Assets
$570,344
total Debt
$2,358,409
net Income
$13,907
eps
N/A
gross Margin
N/A
cash Position
$305
revenue Growth
-100.0%

Revenue Breakdown

SegmentRevenueGrowth
Rental Income$0-100.0%

Key Numbers

Key Players & Entities

FAQ

Why did CANNABIS SUISSE CORP. report net income despite having no revenue?

CANNABIS SUISSE CORP. reported a net income of $13,907 for the three months ended August 31, 2025, primarily due to a $114,739 amortization of debt premium and the absence of a $551,677 loss on settlement of debt that occurred in the prior year. These are non-operating income items, as the company's rental income was $0 for the period.

What is the primary risk factor for CANNABIS SUISSE CORP. investors?

The primary risk factor for CANNABIS SUISSE CORP. investors is the 'substantial doubt about the Company's ability to continue as a going concern,' as stated in Note 3. This is evidenced by an accumulated deficit of $3,043,139 and the complete lack of operational revenue, with rental income dropping to $0 for the quarter ended August 31, 2025.

How has CANNABIS SUISSE CORP.'s revenue changed year-over-year?

CANNABIS SUISSE CORP.'s revenue has drastically declined year-over-year. For the three months ended August 31, 2025, the company reported $0 in rental income, a significant drop from $7,500 in rental income reported for the same period in 2024.

What is CANNABIS SUISSE CORP.'s cash position as of August 31, 2025?

As of August 31, 2025, CANNABIS SUISSE CORP. had a very limited cash position, with only $305 in its escrow account. This represents a decrease from $2,850 as of May 31, 2025, indicating declining liquidity.

What are the implications of CANNABIS SUISSE CORP.'s reliance on related party funding?

CANNABIS SUISSE CORP.'s reliance on related party funding, with advances from related parties increasing by $9,000 to $28,400, suggests that the company is unable to secure sufficient external financing. This indicates a lack of independent financial viability and raises questions about the sustainability of its operations without continued insider support.

What is the company's accumulated deficit as of August 31, 2025?

As of August 31, 2025, CANNABIS SUISSE CORP. reported an accumulated deficit of $3,043,139. This substantial deficit highlights the company's history of losses and contributes to the concerns about its long-term financial stability.

Did CANNABIS SUISSE CORP. have any legal proceedings or contingent liabilities?

As of August 31, 2025, CANNABIS SUISSE CORP. stated that it was not aware of any contingent liabilities that should be reflected in the financial statements. The company evaluates potential litigation in the normal course of business.

What is the nature of CANNABIS SUISSE CORP.'s business operations?

CANNABIS SUISSE CORP. started its real estate business in February 2023, leasing properties from companies owned by its CEO, one of which was subleased for rental revenue. In February 2024, it leased two additional properties for future expansion. However, as of August 31, 2025, it reported no rental income.

How many shares of common stock are outstanding for CANNABIS SUISSE CORP.?

As of October 9, 2025, there were 70,680,938 shares outstanding of CANNABIS SUISSE CORP.'s common stock. This number remained consistent from May 31, 2025, to August 31, 2025.

What is the impact of ASC 2024-03 on CANNABIS SUISSE CORP.?

CANNABIS SUISSE CORP. is currently evaluating ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures. The company expects that these amendments will only impact disclosures and are not anticipated to have an impact on its financial condition and results of operations.

Risk Factors

Industry Context

The cannabis industry continues to navigate a complex regulatory landscape, with evolving state-by-state legalization and federal uncertainty impacting market access and operational costs. Companies face intense competition, pressure on pricing, and challenges in securing traditional financing due to the industry's legal status.

Regulatory Implications

The cannabis sector is subject to stringent and varied regulations across different jurisdictions, impacting product development, marketing, and distribution. Compliance with these evolving rules is critical and can lead to significant penalties or operational disruptions if not managed effectively.

What Investors Should Do

  1. Scrutinize the sustainability of reported net income, given its reliance on non-operational factors like debt premium amortization and the absence of prior-year debt settlement losses.
  2. Assess the viability of the business model given the complete cessation of rental income, the company's primary revenue source.
  3. Evaluate the risks associated with the company's heavy reliance on related party funding and the substantial accumulated deficit.
  4. Monitor any future disclosures regarding the company's ability to address its going concern status and secure sustainable revenue streams.

Glossary

Accumulated Deficit
The total net losses of a company that have not been offset by net income since its inception. (Indicates the company's history of unprofitability and contributes to the going concern assessment.)
Amortization of Debt Premium
The process of gradually writing off the premium paid on a debt instrument over its remaining life. This is a non-cash expense. (A significant non-cash item that artificially boosted net income in the current period, masking underlying operational issues.)
Going Concern
An accounting assumption that a business will continue to operate for the foreseeable future. (The company's financial condition raises substantial doubt about its ability to continue as a going concern, a critical warning for investors.)
Advances From Related Parties
Funds provided to the company by individuals or entities closely connected to the company's management or ownership. (Highlights the company's reliance on insider financing, which can carry specific risks and potential conflicts of interest.)
Convertible Notes Payable - Related Party
Debt instruments that can be converted into equity, owed to parties related to the company. (Represents a significant liability owed to insiders, with potential future dilution if converted.)

Year-Over-Year Comparison

Compared to the prior year's three-month period, CANNABIS SUISSE CORP. (CSUI) reported a significant swing from a net loss of $535,086 to a net income of $13,907. This improvement was driven by non-operational factors, specifically a $114,739 amortization of debt premium and the absence of a $551,677 loss on settlement of debt. However, the company's rental income has completely disappeared ($0 vs. $7,500), and operating expenses have increased, further highlighting the precarious financial situation despite the reported profit.

Filing Stats: 4,674 words · 19 min read · ~16 pages · Grade level 13.2 · Accepted 2025-10-10 16:16:57

Key Financial Figures

Filing Documents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION 1

Financial statements

Item 1. Financial statements. 1

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. 14

Quantitative and Qualitative Disclosures about Market Risk

Item 3. Quantitative and Qualitative Disclosures about Market Risk. 16

Controls and Procedures

Item 4. Controls and Procedures. 17

- OTHER INFORMATION

PART II - OTHER INFORMATION 18

Legal Proceedings

Item 1. Legal Proceedings. 18

Risk Factors

Item 1A. Risk Factors. 18

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 18

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities. 18

Mine Safety Disclosure

Item 4. Mine Safety Disclosure. 18

Other Information

Item 5. Other Information. 18

Exhibits

Item 6. Exhibits. 18

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial statements

Item 1. Financial statements. The accompanying condensed interim financial statements of Cannabis Suisse Corp. (the "Company") should be read in conjunction with the 10-K that was filed with the United States Securities and Exchange Commission (the "SEC"). The accompanying condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, since they are interim statements, the accompanying condensed financial statements do not include all the information and notes required by GAAP for complete financial statement presentation. In the opinion of management, the condensed interim financial statements reflect all adjustments (consisting of normal, recurring adjustments) that are necessary for a fair presentation of the financial position, results of operations, and cash flows for the interim periods presented. Interim results are not necessarily indicative of results for a full year. In the opinion of management, the condensed financial statements contain all material adjustments, consisting only of normal adjustments considered necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented. 1 CANNABIS SUISSE CORP. CONDENSED BALANCE SHEETS August 31, 2025 May 31, 2025 (Unaudited) ASSETS Current Assets Cash in Escrow Account $ 305 $ 2,850 Prepaid Expenses 88,115 103,991 Total Current Assets 88,420 106,841 Property and Equipment, net 19,307 20,368 Operating Leases Right of Use Assets 462,617 507,866 TOTAL ASSETS $ 570,344 $ 635,075 LIABILITIES & STOCKHOLDERS' DEFICIT Current Liabilities Accounts Payable $ 17,500 $ 7,775 Accrued Interest - Related Parties 74,505 58,208 Advances From Related Parties 28,400 19,4

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing